The global pharmaceutical chemicals market size was USD 115.45 billion in 2023, calculated at USD 123.42 billion in 2024 and is projected to surpass around USD 240.52 billion by 2034, expanding at a CAGR of 6.9% from 2024 to 2034.
Pharmaceutical Chemicals Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Chemicals Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Chemicals Market Revenue and Volume, By Product, 2024-2034
8.1.1 Basic building blocks
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Advanced intermediates
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Active ingredients
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Pharmaceutical Chemicals Market Revenue and Volume, By Application, 2024-2034
9.1.1. Cardiovascular
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Neurology
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Oncology
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Infectious diseases
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Metabolic system
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1.6. Diabetes
9.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1.7. Respiratory diseases
9.1.7.1. Market Revenue and Volume Forecast (2021-2034)
9.1.8. Gastrointestinal diseases
9.1.8.1. Market Revenue and Volume Forecast (2021-2034)
9.1.9. Musculoskeletal diseases
9.1.9.1. Market Revenue and Volume Forecast (2021-2034)
9.1.10. Others
9.1.10.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.1.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.2.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.5.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, By Application (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, By Application (2021-2034)
11.1. BASF
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Lonza
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Porton Fine Chemicals
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Dishman
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Lanxess
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Johnson Matthey
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Vertellus Holdings
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Jubilant Life Sciences
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Hikal
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Abbott
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample